SCHEMBL8004911

SCHEMBL8004911

CC1CCN(C2CCN(C(=O)C3CC3)CC2)CC1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.52
KDM4E B2RXH2 2/20 0.49
POLB P06746 1/20 0.49
HPGD P15428 1/20 0.48
CHRNB2 P17787 1/20 0.46
CHRNA3 P32297 1/20 0.46
CHRNA4 P43681 1/20 0.46
CHRNB3 Q05901 1/20 0.46
CHRNA6 Q15825 1/20 0.46
CYP3A4 P08684 1/20 0.45
CYP2C19 P33261 1/20 0.45
CHRM1 P11229 2/20 0.44
CHRM2 P08172 1/20 0.44
ALDH1A1 P00352 3/20 0.44
TSHR P16473 1/20 0.44
KMT2A Q03164 5/20 0.43
MEN1 O00255 4/20 0.43
HTT P42858 1/20 0.43
NPC1 O15118 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10039301 0.88 HPGD (0.60) LMNAHPGDCHRNB2CHRNA3CHRNA4
SCHEMBL24480430 0.86 HPGD (0.58) LMNAHPGDCHRNB2CHRNA3CHRNA4
SCHEMBL22179231 0.85 ALDH1A1 (0.50) LMNAKDM4EHPGDCHRNB2CHRNA3
SCHEMBL25856197 0.83 LMNA (0.45) LMNAKDM4EHPGDALDH1A1TSHR
SCHEMBL19203828 0.81 HTT (0.61) LMNAHPGDCHRNB2CHRNA3CHRNA4
SCHEMBL8226164 0.81 LMNA (0.49) LMNAHPGDCHRNB2CHRNA3CHRNA4
SCHEMBL15450906 0.81 KDM4E (0.51) LMNAKDM4EPOLBCYP3A4CYP2C19
SCHEMBL21087637 0.81 HPGD (0.63) LMNAKDM4EHPGDCHRNB2CHRNA3
SCHEMBL17546310 0.81 HPGD (0.52) LMNAKDM4EHPGDCHRNB2CHRNA3
SCHEMBL18949269 0.81 KDM4E (0.56) KDM4EPOLBCYP3A4CYP2C19CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009108117-A1 MUSCARINIC RECEPTOR AGONISTS, COMPOSITIONS, METHODS OF TREATMENT THEREOF, AND PROCESSES FOR PREPARATION THEREOF 177 ASTRAZENECA AB (SE) 2009-09-03 WO disclosed